A “99% pure” claim on a vial is only as useful as the evidence behind it. For a laboratory, high purity means a stated analytical method, a measured result and a report tied to the exact lot on the bench. This guide explains what purity means, what the usual tests do and do not show, how to check a Certificate of Analysis (COA), and how to handle the material once it arrives. Everything here concerns in-vitro laboratory work by qualified researchers.
TL;DR
- Purity is method-dependent. A credible claim names the method, the specification and the physical lot that was tested.
- HPLC estimates relative purity, but alone it cannot prove identity, quantity or the absence of toxic impurities.
- Purity is not peptide content: water and counterions are part of the powder you weigh.
- Check that the COA matches your lot, identify the testing laboratory and confirm the report with that laboratory.
- Keep lot-level records and store lyophilized peptide cold, dry and protected from light.
Table of Contents
- What “high purity” means for a research peptide
- What HPLC shows, and what it does not
- What a Certificate of Analysis should contain
- How to confirm a COA matches the batch you received
- Traceability: the records worth keeping
- Canadian rules and institutional requirements
- Handling and storage: keeping purity once the vial arrives
- Where TrueLabs fits
- Perspective: why we put the paperwork first
- FAQ
- Sources
What “high purity” means for a research peptide
Purity describes the fraction of the material that is the target peptide rather than related impurities, such as truncated sequences, deletion products or residues left from synthesis. It is a relative figure, and the number only makes sense alongside the application. One university peptide facility, for example, supplies peptides above 95% purity for quantitative bioassays, quantitative enzyme studies, NMR, ELISA, crystallization, ITC and structure-activity work. So 95% is an established working threshold for many assays, and a 99% claim is a stricter specification that needs stronger evidence.
The figure also says nothing by itself about where it came from. The same peptide can be reported at different purities depending on the column, the gradient, the detection wavelength and how peaks are integrated. That is why the method matters as much as the percentage.
Purity is not peptide content
The two terms are often confused. The same facility notes that purity should not be confused with peptide content: lyophilized peptides contain water and counterions such as trifluoroacetate or acetate, and they are usually hygroscopic. A vial labelled 5 mg may therefore hold noticeably less than 5 mg of actual peptide, even if its chromatographic purity is excellent.
This has a practical consequence for anyone preparing stock solutions. If you calculate molarity from the label weight without considering content, your working concentration will be overstated. Amino acid analysis can determine net peptide content, which excludes water and counterions from the measured amount. For assays where exact concentration drives the result, ask whether net content has been measured.

What HPLC shows, and what it does not
Reversed-phase HPLC with UV detection is the standard first test. It separates the components of a sample and compares the area of the target peak with the total peak area, giving a relative purity. According to a widely cited set of recommendations on peptide handling and quantification, HPLC-UV is a standard tool for estimating relative purity, but it cannot alone prove identity, quantity or the absence of toxic impurities.
There are three limits worth keeping in mind:
- Relative signal only. A peak that absorbs weakly, or one that co-elutes with the main peak, can be missed or hidden.
- No identity confirmation. A clean single peak shows that one dominant species is present. It does not show that the species has the correct sequence. Mass spectrometry is the usual companion test for molecular weight.
- No statement on potency or safety. One published guide to purity testing makes the point that a COA is evidence, not an absolute safety guarantee, because HPLC cannot alone prove sequence or biological potency.
For a deeper look at how the two techniques complement each other, see our guide to peptide purity with HPLC and mass spec.
Validated methods matter
An analytical result is only dependable if the procedure behind it is fit for purpose. Health Canada’s adoption of the ICH Q2 guideline states that analytical procedures should be validated to show suitability for their intended purpose, with characteristics such as accuracy, precision and specificity. That guideline is written for pharmaceutical submissions, and a research supplier is not held to it. It is still a useful yardstick: a good report should let you see how the measurement was made.
What a Certificate of Analysis should contain
A COA is a document, not a guarantee. Its value depends on what it records. Health Canada’s good manufacturing practices guidance describes a certificate of analysis as including the testing laboratory’s name and address, the material name and specifications, the tests and methods, actual numerical results, approval dates and the approver’s signature.
Translated into a bench-level checklist for a peptide COA:
| Element | What to look for | Why it matters |
|---|---|---|
| Laboratory identity | Name and address of the testing laboratory | Lets you contact the lab and confirm the report |
| Material and lot | Peptide name, lot or batch number | Ties the result to the vial you hold |
| Method | HPLC conditions, mass spectrometry technique | Purity depends on the method used |
| Specification | The acceptance limit, such as a minimum purity | Shows what the result was measured against |
| Numerical results | Actual purity value and observed mass | A bare “pass” tells you nothing |
| Dates and approval | Test date, signature or approver | Shows the report was reviewed |
Our walkthrough of how to read a peptide COA goes through chromatograms and common red flags in more detail.
How to confirm a COA matches the batch you received
A beautiful report for the wrong lot is worthless. One practical guide to purity testing explains that researchers can verify purity by checking that the COA matches the product and lot received, identifying the testing laboratory and verifying the report’s authenticity with that laboratory. It adds that independent testing does not by itself establish sample provenance or reliability. In other words, a third-party lab can only vouch for the sample it was given.
A sensible routine on receipt:
- Compare the lot number on the vial label, the packing slip and the COA.
- Check that the peptide name and, where stated, the observed molecular mass fit the expected value.
- Look for the method, the specification and the numerical result. Another published guide makes the point that a credible quality claim states the method, specification and physical lot tested.
- Contact the named laboratory to confirm that the report exists and that its content is unchanged.
- File the COA with your receiving record before the vial is opened.
For work that will feed into a regulatory file, expectations are higher again. Health Canada’s quality guidance for new drug submissions expects batch analysis results from at least two separate lots to demonstrate manufacturing consistency. Basic in-vitro research seldom needs that, but the principle holds: one good lot is a data point, and consistency across lots is the real signal.
Traceability: the records worth keeping
Purity evidence is only half of procurement. The other half is a record that lets you reconstruct, months later, exactly what went into an experiment. Drawing on the verification steps above, a minimal traceability file for each peptide lot includes:
- the supplier’s order confirmation, with date, product and quantity;
- the lot number and the matching COA, saved in the form you received it;
- the name of the testing laboratory and the date you confirmed the report;
- the date of receipt, storage location and storage temperature;
- the date of each reconstitution, the solvent and concentration used, and how many aliquots were made;
- the experiments in which each aliquot was used.
Treat this as good practice rather than a legal formula. Your institution’s own policies set the formal requirements, and your biosafety or procurement office can tell you what they are.
Canadian rules and institutional requirements
Research peptides are bought and used inside a framework of workplace and institutional rules. A few points from official Canadian sources:
- Labelling. Under WHMIS 2015, laboratory samples under 10 kg intended solely for laboratory testing generally require supplier labels unless an exemption applies.
- Lab inspections. The federal laboratory inspection guideline checks for up-to-date chemical inventories, fume hoods where processes generate airborne contaminants and proper labelling of hazardous substances. Your lot-level records support the inventory part of that.
- Controlled substances. The Controlled Drugs and Substances Act prohibits activities such as possession and production of controlled substances unless authorized or exempted, and researchers must obtain permission to have a controlled substance for research. The same page notes that Health Canada may take enforcement action when requirements are not followed, with record-keeping among them, and that replacement regulations take effect on October 1, 2026.
Most research peptides are not controlled substances, but the status of a specific compound is something to confirm with your institution before ordering. For regulatory context on one widely discussed compound, see our Retatrutide Canada guide, and for the wider picture, our overview of research peptides in Canada.
Handling and storage: keeping purity once the vial arrives
A 99% peptide can degrade on a poorly managed shelf. The published recommendations on peptide handling advise storing peptides in dark tubes under an inert gas, with long-term storage as a lyophilized powder at -20 °C to -80 °C. For storage beyond six months, the same source recommends dry powder under argon or nitrogen, or in a desiccator, at -20 °C or lower.
In practice:
- Keep lyophilized material sealed and cold until you need it, and let the vial reach room temperature before opening to limit condensation, since peptides are hygroscopic.
- Reconstitute only what the experiment needs and divide the rest into single-use aliquots, because repeated freeze-thaw cycles are best avoided.
- Rinse pipette tips with the solution to reduce adsorption losses, and consider silanized glass containers for dilute solutions.
If you are new to the field, our introduction to peptides covers the underlying chemistry.
Where TrueLabs fits
We built TrueLabs around the checks described above. Every batch is independently verified by a third-party laboratory and accompanied by a batch-specific Certificate of Analysis, and we state a guaranteed 99% purity for our research compounds. As a Canadian company we ship within Canada, so there are no customs fees or border delays, and packaging is discreet. Our catalogue covers BPC and thymosin class peptides, GH secretagogues, incretin analogues, mitochondrial peptides, melanocortin agonists, gonadotropins, neuropeptides and lab supplies, alongside plain-language research summaries and reconstitution calculation tools.
Our products are sold for in-vitro research by qualified researchers at academic institutions, biotech companies and commercial laboratories, and not for personal use. You can browse the full range on the TrueLabs catalogue, or look at individual compounds such as Kisspeptin, DSIP and Pinealon.
Perspective: why we put the paperwork first
The research peptide market has long suffered from opacity: a purity percentage on a label, no method behind it, and no way to tie it to the vial in your hand. We think that is the wrong way round. The number is the least informative part of a quality claim; the method, the lot and the laboratory are what make it checkable.

That is also why we are careful about what a COA can promise. HPLC gives relative purity, mass spectrometry supports identity, and neither replaces your own judgement or your own controls. We would rather a researcher read the report critically, call the testing laboratory and compare lots over time than take our word for anything. Third-party verification protects you from markups and uncertainty, but it works best when you treat it as evidence to be examined.
We also hold a cautiously optimistic view of peptides in general. They are valuable laboratory tools, and the quality of the material is one of the variables you can control. Everything we publish is for research use, and none of it is medical advice.
— Matis
FAQ
Tap a question to reveal the answer.
Is 99% purity always better than 95%?
Not automatically. Many bioassays, ELISA and NMR applications are routinely performed with peptide above 95% purity, as university facilities state. A higher figure is valuable when trace impurities could affect the result, but only if the method and lot are documented.
Does a high HPLC purity mean the peptide is the right one?
No. HPLC compares peak areas and cannot alone prove identity, quantity or the absence of toxic impurities. Mass spectrometry results on the same COA help confirm that the molecular weight matches the expected peptide.
Why is my peptide weight lower than the label suggests?
Lyophilized peptides contain water and counterions such as trifluoroacetate or acetate, so the net peptide content is lower than the total powder weight. Amino acid analysis can measure net content. Check whether your supplier reports it before calculating molar concentrations.
How do I know a COA is genuine?
Confirm that the lot number matches your vial, find the testing laboratory’s name and address on the report, and contact that laboratory to verify the document. Independent testing alone does not establish where a sample came from, so the lot match is the essential step.
How should I store research peptides?
Keep them as lyophilized powder at -20 °C to -80 °C, protected from light and ideally under an inert gas or in a desiccator. Avoid repeated freeze-thaw cycles by dividing reconstituted material into single-use aliquots.
Sources
- General Description of Services, UNC Peptide Facility
- Recommendations for the generation, quantification, storage and handling of peptides (PMC)
- Peptide Purity Testing: HPLC, MS, Assay, and COAs
- Lab Testing 101: Read a Peptide COA
- ICH Q2(R1) analytical validation, Health Canada
- Good manufacturing practices guide, glossary, Health Canada
- Quality (Chemistry and Manufacturing) guidance for new drug submissions, Health Canada
- Labelling requirements for hazardous products in laboratories, ESDC
- Laboratory Inspection Guideline, ESDC
- Regulating controlled substances and precursors, Health Canada
